跳至主要内容

Medicilon Human Disease Animal Model

 Medicilon provides various effective animal models according to customer needs to test the effectiveness of drugs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, and guinea pigs. At present, we have established a number of effective animal models, and have passed multiple verifications and long-term practical tests. At the same time, our employees' rich experience and strong theoretical foundation can flexibly develop and build various customized models according to customer's customization requirements to meet customer needs.

animal model

Tumor disease model

Medicilon provides various effective animal models according to customer needs to test the effectiveness of drugs. Experimental animals include non-human primates, dogs, mice, rats, rabbits, guinea pigs, and nude mice. At present, we have established a number of effective animal tumor models, and have passed multiple verifications and long-term practical tests. At the same time, our employees' rich experience and strong theoretical foundation can flexibly develop and build various customized tumor disease models according to customer's customization requirements to meet customer needs. see more

Type of cancer (tumor model)Cell line
Head and neck tumor modelKB, FaDu
Animal model of nasopharyngeal carcinoma
Stem cell animal model 		S18, S26
Lung cancer animal modelsDMS114, NCI-H69, NCl-H146, NCl-H209, NCI-H446, NCI-H526, NCI-H1688, 95-D, A549, Calu-1, Calu-3, Calu-6, HCC827, NCI -H226, NCI-H292, NCI-H358, NCI-H441, NCI-H460, NCI-H520, NCI-H522, NCI-H1299, NCI-H1437, NCI-H1650, NCI-H1975, NCI-H1993, NCI-H2009 , NCI-H2122, NCI-H2126, NCI-H2228, PC-10, QG-56
Breast cancer animal modelsSUM159, MDA-MB-231, MDA-MB-468, Bcap-37, 2LMP, ZR-75-1, ZR-75-30
Animal model of gastric cancerMKN-45, NCI-N87, BGC-823, HGC-27, MKN-28, NUGC-3, SCH, SGC-7901, SNU-5, SNU-16, MGC-803
Animal model of pancreatic cancer AsPC-1, BxPC-3, Capan-1, Capan-2, CFPAC-1, HPAF-II, MIAPaCa-2, PANC-1
Kidney cancer animal modelACHN, OS-RC-2, 786-O
Liver cancerBel-7402, Hep-3B, Huh-7, PLC/PRF/5, QGY-7703, SK-HEP-1, SMMC-7721, HepG-2
Glioblastoma U87-MG
Colon and cecum cancersCOLO 201, COLO 205, COLO 320 DM, CW-2, DLD-1, HCT-8, HCT-15, HCT-116, HCT116 P53 K0(-/-), HT-29, LoVo, LS1034 , LS174T, LS411N, NCI-H716, RKO, SW48, SW620
Prostate cancer 22Rv1, CL-1, DU145, LNCap Clone FGC, PC-3
Bladder HT-1197, HT-1376, RT4, SCaBER, SW780, T24
Ovarian cancerES-2, HO-8910PM, PA-1, SK-OV-3, OVCAR-3
Endometrium / HysterocarcinomaAN3 CA, HEC-1-A, ME-180, MFE-280
Skin cancer cellA431
MelanomaA375, B16, A2058, C32, HMCB, SK-MEL-30, MDA-MB-435s
Osteosarcoma cellsMG-63, SJSA-1
Sarcoma S-180
Muscles, stripes SJCRH30
Myeloma KMS-11, KMS-26, RPMI-8226
Leukemia/lymphomaU937, THP-1, MV-4-11, HEL, TF-1a, ML-2, HL-60, L1210, K562, KARPAS-299, Daudi, Raji, Ramos, ARH-77, KMS- 12-BM, KG-1

Digestive system disease model

Medicilon provides various effective animal models (renal failure model, anemia animal model, gastric acid secretion animal model, gastric ulcer model, etc.) according to customer needs to test the effectiveness of drugs. Conventional diseases of the digestive system include: gastric acid secretion, gastric ulcer, renal failure, etc. Animal experiments are carried out in rats. see more

diseaseThe Digestive system disease modelThe Test animal
Renal failureThe Nephrectomy (5/6)The Rat
anemiaThe Renal failure induction The Rat
Gastric acid secretionThe Histamine gastric acid secretion model The Rat
The Pylorus ligation model of gastric acid secretion The Rat
The Ethanol gastric ulcer model The Rat
Gastric ulcerAspirin gastric ulcer model The Rat

Endocrine and Metabolic Disease Model

Medicilon provides a variety of effective endocrine disease models and animal models of metabolic diseases according to customer needs to test the effectiveness of drugs. Conventional endocrine diseases and metabolic diseases include: diabetes, obesity, dyslipidemia, etc. Animal experiments are conducted with large mice and hamsters. see more

DiseaseEndocrine and Metabolic Disease ModelAnimal
DiabetesStreptozotocin DiabetesMice
Spontaneously diabeticdb/db, ob/ob mice
Obese mice induced by high-fat diet DIO mice
Obesity Hereditarydb/db, ob/ob mice
Obese mice induced by high-fat dietDIO mice
Dyslipidemia High fat/cholesterolHamster

Inflammation and immune disease models

Medicilon provides various effective inflammatory disease models and animal models of immune diseases according to customer needs to test the effectiveness of drugs. Conventional inflammation and immune diseases include: acute inflammation, arthritis, experimental allergic encephalomyelitis, etc. Animal experiments are conducted with large mice. see more

Nervous system disease model
Medicilon provides a variety of effective animal models (depression animal models, Parkinson's disease animal models, psychotic animal models, etc.) according to customer needs to test the effectiveness of drugs. Routine neurological diseases include: psychosis, Parkinson's disease, depression, pain (central), etc. Animal experiments are conducted with large mice and guinea pigs. see more

Contact us

Email: Marketing@medicilon.com

Phone: 021 58591500

The relevant content of the above disease animal models is officially provided by Medicilon.

Related Articles:

Medicilon Tumor Modeling Service

Nude mice tumor formation experiment

Animal model of diabetes melitus

Medicilon Drug Screening Model Service

标签：

评论

发表评论

此博客中的热门博文

Medicilon and Binhui Biopharmaceutical Have Reached a Strategic Collaboration to Jointly Draw a New Blueprint for the Development of New Biological Drugs

  On March 18, Medicilon and Binhui Biopharmaceutical (Binui Bio) announced a strategic collaboration.  The two parties will work together to jointly explore the possibilities in cutting-edge fields such as oncolytic viruses, nucleic acid drugs and protein drugs. Gather and Work Together to Create Advantages      Facilitate the Research and Development of Oncolytic Viruses, Nucleic Acids, Proteins and Other Drugs As a one-stop biopharmaceutical comprehensive preclinical R&D service CRO, Medicilon has been developing and accumulating for 20 years, always adhering to the spirit of innovation, and has successfully constructed bi/multi-specific antibodies,  ADCs ,  mRNA vaccines ,  small nucleic acid drugs ,  PROTAC , and  CGT technical service platform  that have helped 421 INDs obtain clinical approval.  It is this outstanding achievement that has earned Medicilon wide recognition in the industry and laid a solid foundation f...
发表评论
阅读全文

The Launch Meeting was Held by Medicilon and DAC Biotech of the Contract Research on ADC Preclinical Study

  Chuansha, Shanghai, Nov. 8th, 2019 — Medicilon held the launch meeting with Hangzhou DAC Biotech Co., Ltd to initiate the   preclinical study   of the antibody-drug-conjugate (ADC)  DXC005, including the   pharmacology study ,   DMPK study   and the   safety evaluation . Medicilon has previously completed integrated  preclinical research  on ADC drugs cooperating with DAC Biotech and other companies. Two of them has been approved by NMPA and entered Phase I clinical trials. About Hangzhou DAC Biotech Co., Ltd Hangzhou DAC Biotech, Co., Ltd was officially registered in HEDA Area, Hangzhou City, Zhejiang Province, China around the end of Year 2012, and is located nearby the bank of beautiful Qiantang River. The company focuses on developing conjugate of monoclonal antibody and small molecular cytotoxic drug, both of which are banded together with smart linkers. About Antibody-Drug-Conjugate (ADC) ADCs ...
发表评论
阅读全文

A Nickel-Catalyzed Reductive Alkylation of Aryl Bromides and Chlorides for Sp3-Sp2 Bond Formation

  In 2012, a nickel-catalyzed reductive alkylation method of aryl bromides and chlorides was reported. Under the optimized conditions, a variety of aryl and vinyl bromides as well as active aryl chloride can be reductively coupled with alkyl bromides in high yields. The protocols were highly functional-group tolerant and the reactions were not air or moisture sensitive. The reaction showed different chemoselectivity than conventional cross-coupling reactions. Substrates bearing both anelectrophilic and nucleophilic carbon resulted in selective coupling at the electrophilic carbon (R-X) and no reaction occurred at the nucleophilic carbon (R-[M]). The 2010 Nobel Prize in Chemistry was awarded for the Pd-catalyzed cross-coupling, and in the past decade the progress in cross-coupling has not only had a significant impact on academic research but has also influenced the industrial synthetic application. The transition-metal-catalyzed union of nucleophilic organo-boronic acids with elect...
发表评论
阅读全文